Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.95%
0%
-6.95%
6 Months
-12.57%
0%
-12.57%
1 Year
4.79%
0%
4.79%
2 Years
9.49%
0%
9.49%
3 Years
8.73%
0%
8.73%
4 Years
-14.25%
0%
-14.25%
5 Years
-10.3%
0%
-10.3%
bioMérieux SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.46%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
67.90
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
0.94
Tax Ratio
22.70%
Dividend Payout Ratio
24.56%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
18.06%
ROE (avg)
13.41%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
3.38
EV to EBIT
21.08
EV to EBITDA
13.83
EV to Capital Employed
3.38
EV to Sales
3.23
PEG Ratio
1.17
Dividend Yield
NA
ROCE (Latest)
16.01%
ROE (Latest)
12.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,979.90
3,674.70
8.31%
Operating Profit (PBDIT) excl Other Income
893.30
795.10
12.35%
Interest
16.00
4.40
263.64%
Exceptional Items
-19.40
-125.90
84.59%
Consolidate Net Profit
425.10
322.80
31.69%
Operating Profit Margin (Excl OI)
148.50%
145.80%
0.27%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 8.31% vs 2.38% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 31.69% vs -26.72% in Dec 2023
About bioMérieux SA 
bioMérieux SA
Pharmaceuticals & Biotechnology
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.
Company Coordinates 
Company Details
376 chemin de l'Orme , MARCY-L ETOILE None : 69280
Registrar Details






